プロモーションスケジュール Oculis Holding AG
詳細なスケジュール
簡易グラフ
会社について
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. さらに詳しく| IPO date | 2023-03-02 |
|---|---|
| ISIN | CH1242303498 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | chf |
| Сайт | https://oculis.com |
| Цена ао | 12.65 |
| 1日あたりの価格変動: | -0.6444% (17.07) |
|---|---|
| 週ごとの価格変動: | -0.1178% (16.98) |
| 月ごとの料金変更: | +4.95% (16.16) |
| 3ヶ月間の価格変動: | +37.76% (12.3116) |
| 半年間の価格変動: | +44.65% (11.725) |
| 年間の価格変動: | +51.02% (11.23) |
| 3年間の価格推移: | +74.67% (9.71) |
| 5年間の価格推移: | 0% (16.96) |
| 10年間の価格推移: | 0% (16.96) |
| 年初からの価格変動: | +10.34% (15.37) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Pivotal bioVenture Partners Investment Advisor, LLC | 1888788 | 4.66 |
| Abrdn PLC | 1452741 | 3.59 |
| Nan Fung Group Holdings Limited | 518933 | 1.28 |
| Compagnie Lombard Odier SCmA | 95750 | 0.24 |
| Bank of America Corporation | 16926 | 0.04 |
| Searle & Co. | 10000 | 0.02 |
| Dupont Capital Management Corp | 4 | 0 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Dr. Riad Sherif M.B.A., M.D. | CEO & Director | N/A | 1968 (57 年) |
| Ms. Sylvia Cheung | Chief Financial Officer | N/A | 1975 (50 年) |
| Mr. Páll Ragnar Jóhannesson | Chief Business Officer | N/A | 1982 (43 年) |
| Ms. Rebecca Weil | Chief Commercial Officer | N/A | |
| Dr. Ramin Tadayoni M.D., Ph.D. | Chief Scientific Officer | N/A | |
| Ms. Virginia R. Dean | Chief Human Resources Officer | N/A | 1967 (58 年) |
| Dr. Bastian Dehmel M.D. | Chief Development Officer | N/A | 1971 (54 年) |
| Dr. Snehal Shah Pharm.D. | President of Research & Development | N/A | |
| Dr. Sharon Klier M.D., M.P.H. | Chief Development Officer |
